Lisa Wilson | Investor Relations |
Scott Tarriff | Chief Executive Officer |
Pete Meyers | Chief Financial Officer |
Ashley Ryu | RBC Capital Markets |
Myles Minter | William Blair |
Gregg Gilbert | Deutsche Bank |
David Amsellem | Piper Jaffray |
Good morning. My name is Leo, and I'll be your conference operator today. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Third Quarter 2017 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period.